Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron plus dexamethasone versus dexamethasone alone for postoperative nausea and vomiting after maxillofacial trauma surgery
IRCT20190916044784N2Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ondansetron and dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoint: Reduction of postoperative nausea and vomiting without rescue medication. Started Jun 2023; status: completed.
02
Drugs
ondansetrondexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20190916044784N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190916044784N2.